ChemBriefSenesTech Inc Q1 2026 Earnings Call Transcript
SenesTech Inc reported a 2% overall revenue increase in Q1 2026 despite strong channel-specific growth, impacted by $443,000 in one-time operating expenses.
GuruFocus · 2026-08-11 22:10 UTC
SenesTech Inc reported a 2% overall revenue increase in Q1 2026 despite strong channel-specific growth, impacted by $443,000 in one-time operating expenses.
SenesTech reported a Q1 2026 net loss of $2.1 million despite revenue rising to $493,000, driven by Evolve fertility-control products accounting for 85% of sales. Improved margins support operations t
SenesTech Inc reported strong Q1 2026 results with a record 68.6% gross margin and projected revenue growth despite Amazon channel disruptions. The company will shift focus to direct-to-consumer sales
SenesTech reported a 2% year-over-year revenue increase to $493,000 for Q1 2026, driven by direct-to-consumer growth and a record 68.6% gross margin, while planning to expand its Evolve rodent control
SenesTech reported a Q1 2026 EPS beat and narrower loss, driving a stock surge despite a revenue miss, as investors react positively to its direct-to-consumer strategy and subscription growth.
SenesTech reported Q1 2026 revenue of $493,000 with a record 68.6% gross margin despite a $2.1 million net loss. Growth was driven by direct-to-consumer and subscription channels following an Amazon t
SenesTech reported a 2% revenue increase to $493,000 in Q1 2026 despite widening net losses to $2.1 million due to one-time costs. The company highlighted strong e-commerce growth of 163% year-over-ye